About Generable
Generable is a company based in New York (United States) founded in 2016 by Eric Novik and Daniel Lee.. Generable has raised $120 thousand across 1 funding round from investors including Techstars. Generable offers products and services including Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models. Generable operates in a competitive market with competitors including InSilicoTrials, CONTINUUM India, Cognigen, Pharmetheus and Chrestos, among others.
- Headquarter New York, United States
- Founders Eric Novik, Daniel Lee
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Generable Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$120 K (USD)
in 1 rounds
-
Latest Funding Round
$120 K (USD), Seed
Jun 01, 2017
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Generable
Generable offers a comprehensive portfolio of products and services, including Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Links hazards with biomarkers for accurate health predictions.
Simulates drug behavior using ODE solvers for pharmacokinetics.
Provides predictions with uncertainties for biomarker evaluation.
Unlock access to complete
Unlock access to complete
Stan Team
1 people
Advisor Team
1 people
Leadership Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of Generable
Generable has successfully raised a total of $120K through 1 strategic funding round. The most recent funding activity was a Seed round of $120 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $120,000
-
First Round
First Round
(01 Jun 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Seed - Generable | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Generable
Generable has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Techstars. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Generable
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Generable
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Generable Comparisons
Competitors of Generable
Generable operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InSilicoTrials, CONTINUUM India, Cognigen, Pharmetheus and Chrestos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Healthcare simulation services are provided for medical applications worldwide.
|
|
| domain | founded_year | HQ Location |
Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharma firms.
|
|
| domain | founded_year | HQ Location |
Strategic clinical pharmacology and pharmacometric consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Offers pharmacometric services to support efficient and effective drug development processes.
|
|
| domain | founded_year | HQ Location |
Pharmacokinetic and pharmacodynamic study services are offered by this CRO.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Generable
When was Generable founded?
Generable was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Generable located?
Generable is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Generable?
Eric Novik is the current CEO of Generable. They have also founded this company.
Is Generable a funded company?
Generable is a funded company, having raised a total of $120K across 1 funding round to date. The company's 1st funding round was a Seed of $120K, raised on Jun 01, 2017.
What does Generable do?
Generable was founded in 2016 in New York, United States, within the precision medicine sector. Statistical machine learning is utilized to develop models for preclinical and clinical drug development, including Bayesian computing approaches. Focus is placed on neuroscience, immuno-oncology, rare diseases, and personalized decision-making, with pharmacometrics, genomic, and brain network models employed. Services are provided to clients such as Sanofi and AstraZeneca.
Who are the top competitors of Generable?
Generable's top competitors include InSilicoTrials, Chrestos and Incite Health.
What products or services does Generable offer?
Generable offers Joint Outcome-Biomarker Models, Complex PK/PD Models, and Biomarker Screening Models.
Who are Generable's investors?
Generable has 1 investor. Key investors include Techstars.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.